Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium
Primary Purpose
Critical Illness
Status
Withdrawn
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
99mTc-Rhenium Sulfide Nanocolloid
Sponsored by
About this trial
This is an interventional diagnostic trial for Critical Illness focused on measuring microaspiration, mechanical ventilation, enteral feeding, 99m technetium, pepsin
Eligibility Criteria
Inclusion Criteria:
- age > or = 18 years
- hospitalised in ICU
- tracheal intubation using a polyvinyl chloride tube and mechanical ventilation
- predictable mechanical ventilation > or = 6 hours after inclusion
- enteral nutrition by a nasogastric tube
Exclusion Criteria:
- refuse to participate to the study
- no informed consent
- pregnant
- contra-indication for enteral nutrition
- tracheotomy
- intubation or re-intubation done in 6 hours preceding the inclusion
Sites / Locations
- ICU, Calmette Hospital, University Hospital of Lille
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
99mTc-Rhenium Sulfide Nanocolloid
Arm Description
99mTc-Rhenium Sulfide Nanocolloid
Outcomes
Primary Outcome Measures
incidence of pepsin levels ≥200 ng / ml
Sensibility and sensitivity of Pepsin for the diagnosis of microaspiration will be determined with regard to 99m technetium (gold standard).
Secondary Outcome Measures
likelihood ratio of pepsin of microregurgitation
Sensibility and sensitivity of Pepsin for the diagnosis of microregurgitation will be determined with regard to 99m technetium.
likelihood ratio of pepsin of microaspiration
positive and negative predictive values, positive and negative likelihood ratio of pepsin for the diagnosis of microaspiration compared to the 99m technetium (gold standard)
Youden Index
Youden Index and ROC curve analysis of the Pepsin as a marker for the diagnosis of microaspiration compared to the 99m Technetium (gold standard)
ROC curve
Youden Index and ROC curve analysis of the Pepsin as a marker for the diagnosis of microaspiration compared to the 99m Technetium (gold standard)
Full Information
NCT ID
NCT02169193
First Posted
June 18, 2014
Last Updated
December 3, 2015
Sponsor
University Hospital, Lille
1. Study Identification
Unique Protocol Identification Number
NCT02169193
Brief Title
Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium
Official Title
Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium
Study Type
Interventional
2. Study Status
Record Verification Date
December 2015
Overall Recruitment Status
Withdrawn
Study Start Date
September 2015 (undefined)
Primary Completion Date
September 2016 (Anticipated)
Study Completion Date
January 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Lille
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Microaspiration of contaminated oropharyngeal secretions and gastric contents frequently occurs in intubated critically ill patients, and plays a major role in the pathogenesis of ventilator-associated pneumonia. Quantitative pepsin measurement in tracheal aspirates would be useful in diagnosing microaspiration of gastric contents in intubated critically ill patients. Technetium 99m labelled enteral feeding is the gold standard for the diagnosis of microaspiration. The investigators hypothesized that tracheal pepsin measurement is a good diagnosis marker of microaspiration compared to the gold standard.
Detailed Description
Microaspiration of contaminated oropharyngeal secretions and gastric contents frequently occurs in intubated critically ill patients, and plays a major role in the pathogenesis of ventilator-associated pneumonia Quantitative pepsin measurement in tracheal aspirates would be useful in diagnosing microaspiration of gastric contents in intubated critically ill patients Technetium 99m labelled enteral feeding is the gold standard for the diagnosis of microaspiration. We hypothesized that tracheal pepsin measurement is a good diagnosis marker of microaspiration compared to the gold standard
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness
Keywords
microaspiration, mechanical ventilation, enteral feeding, 99m technetium, pepsin
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
99mTc-Rhenium Sulfide Nanocolloid
Arm Type
Experimental
Arm Description
99mTc-Rhenium Sulfide Nanocolloid
Intervention Type
Radiation
Intervention Name(s)
99mTc-Rhenium Sulfide Nanocolloid
Other Intervention Name(s)
NanoCis
Intervention Description
12 MBq of NanoCis added to 500 ml of enteral feeding
Primary Outcome Measure Information:
Title
incidence of pepsin levels ≥200 ng / ml
Description
Sensibility and sensitivity of Pepsin for the diagnosis of microaspiration will be determined with regard to 99m technetium (gold standard).
Time Frame
from the start to 6 hours after beginning of 99m technetium labelled enteral feeding
Secondary Outcome Measure Information:
Title
likelihood ratio of pepsin of microregurgitation
Description
Sensibility and sensitivity of Pepsin for the diagnosis of microregurgitation will be determined with regard to 99m technetium.
Time Frame
from the start to 6 hours after beginning of 99m technetium labelled enteral feeding
Title
likelihood ratio of pepsin of microaspiration
Description
positive and negative predictive values, positive and negative likelihood ratio of pepsin for the diagnosis of microaspiration compared to the 99m technetium (gold standard)
Time Frame
from the start to 6 hours after beginning of 99m technetium labelled enteral feeding
Title
Youden Index
Description
Youden Index and ROC curve analysis of the Pepsin as a marker for the diagnosis of microaspiration compared to the 99m Technetium (gold standard)
Time Frame
from the start to 6 hours after beginning of 99m technetium labelled enteral feeding
Title
ROC curve
Description
Youden Index and ROC curve analysis of the Pepsin as a marker for the diagnosis of microaspiration compared to the 99m Technetium (gold standard)
Time Frame
from the start to 6 hours after beginning of 99m technetium labelled enteral feeding
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age > or = 18 years
hospitalised in ICU
tracheal intubation using a polyvinyl chloride tube and mechanical ventilation
predictable mechanical ventilation > or = 6 hours after inclusion
enteral nutrition by a nasogastric tube
Exclusion Criteria:
refuse to participate to the study
no informed consent
pregnant
contra-indication for enteral nutrition
tracheotomy
intubation or re-intubation done in 6 hours preceding the inclusion
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Saad Nseir, MD, PhD
Organizational Affiliation
Univ Hosp of Lille, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
ICU, Calmette Hospital, University Hospital of Lille
City
Lille
ZIP/Postal Code
59037
Country
France
12. IPD Sharing Statement
Learn more about this trial
Diagnosis of Microaspiration in Intubated Critically Ill Patients: Pepsin vs 99m Technetium
We'll reach out to this number within 24 hrs